# FDA Inspection 852226 - Vitalant - October 22, 2013

Source: https://www.keypedia.com/records/fda_inspections/vitalant/c62b4cec-8ac6-4cae-bca2-0136258e7d76
Source feed: FDA_Inspections

> FDA Inspection 852226 for Vitalant on October 22, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 852226
- Company Name: Vitalant
- Inspection Date: 2013-10-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1233322 - 2024-03-13](https://www.keypedia.com/records/fda_inspections/vitalant/455225bf-89f4-426c-a92d-711b48d4c23a)
- [FDA Inspection 1106251 - 2019-08-19](https://www.keypedia.com/records/fda_inspections/vitalant/3a9b71cb-e049-49a7-b46e-ccb93a0ceabe)
- [FDA Inspection 945649 - 2015-10-19](https://www.keypedia.com/records/fda_inspections/vitalant/4ef8788f-481c-4ae2-ae82-3a20599a9511)
- [FDA Inspection 756175 - 2011-12-06](https://www.keypedia.com/records/fda_inspections/vitalant/e89d8517-b9eb-4f63-a123-94bce118044f)
- [FDA Inspection 628530 - 2009-11-10](https://www.keypedia.com/records/fda_inspections/vitalant/a05b6dde-0b5c-4ead-96bd-7118dc5b6451)

Company: https://www.keypedia.com/companies/vitalant/3b4bcbc3-8581-4717-a386-60e17d1639bc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d